Literature DB >> 19258938

Outcome of conservatively treated microinvasive squamous cell carcinoma of the uterine cervix during a 10-year follow-up.

Silvano Costa1, Elena Marra, Giuseppe N Martinelli, Donatella Santini, Paolo Casadio, Guido Formelli, Carla Pelusi, Tullio Ghi, Kari Syrjänen, Giuseppe Pelusi.   

Abstract

UNLABELLED: To assess the rate, the cumulative proportion, and the predictors of cervical intraepithelial neoplasia grades 2-3 (CIN 2-3) and invasive disease during the follow-up of patients conservatively treated for microinvasive (stage Ia1-2) squamous cell carcinoma (MIC) of the uterine cervix.
METHODS: Two hundred thirty women (median age, 37 years; range, 20-69 years) conservatively treated for MIC were followed up for 10 years and analyzed for cumulative proportion of CIN 2-3/invasive disease. The multivariate survival analysis was used to assess the clinicopathological features predicting the development of CIN 2-3/SCC.
RESULTS: Of the 230 patients primarily treated by cone, 76 (33%) underwent hysterectomy as the immediate retreatment, and 13 had a residual disease. The remaining 154 women were subjected to posttreatment follow-up. The depth of stromal invasion was strongly associated with the prevalence of positive lymph nodes and lymphovascular space invasion (LVSI). The detection rate of CIN 2-3/SCC was stable at the first 2 visits (6.5% and 6.9%) and dropped thereafter. The cumulative proportion of patients whose conditions were diagnosed as CIN 2-3/carcinoma was 0.07, 0.09, 0.15, and 0.19 at 6, 12, 36, and 120 months, respectively. In multivariate survival analysis, involvement of 4 quadrants (odds ratio [OR], 5.8), LVSI (OR, 4.5), and cone margin involvement (OR, 5.6) were significant independent predictors of CIN 2-3/SCC after treatment. The upper age tertile (42-69 years) was an independent protective factor (OR, 0.3; 95% confidence interval, 0.1-0.9).
CONCLUSIONS: A close, long-term surveillance should be scheduled for the MIC patients conservatively treated. Cone margin involvement, LVSI, and the number of quadrants involved on colposcopy are independent risk factors for disease persistence and/or progression to SCC.

Entities:  

Mesh:

Year:  2009        PMID: 19258938     DOI: 10.1111/IGC.0b013e318197f53b

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  8 in total

1.  [S3 guidelines on diagnostics and treatment of cervical cancer: Demands on pathology].

Authors:  L-C Horn; M W Beckmann; M Follmann; M C Koch; P Mallmann; S Marnitz; D Schmidt
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

2.  Clinical Epidemiology of Microinvasive Cervical Carcinoma in an Italian Population Targeted by a Screening Programme.

Authors:  Lauro Bucchi; Silvano Costa; Silvia Mancini; Flavia Baldacchini; Orietta Giuliani; Alessandra Ravaioli; Rosa Vattiato; Federica Zamagni; Paolo Giorgi Rossi; Cinzia Campari; Debora Canuti; Priscilla Sassoli de Bianchi; Stefano Ferretti; Fabio Falcini
Journal:  Cancers (Basel)       Date:  2022-04-22       Impact factor: 6.575

Review 3.  Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma.

Authors:  Silvano Costa; Simona Venturoli; Massimo Origoni; Mario Preti; Luciano Mariani; Paolo Cristoforoni; Maria Teresa Sandri
Journal:  Ecancermedicalscience       Date:  2015-04-29

4.  Conservative Treatment of Stage IA1 Adenocarcinoma of the Uterine Cervix during Pregnancy: Case Report and Review of the Literature.

Authors:  Francesco Sopracordevole; Diego Rossi; Jacopo Di Giuseppe; Marta Angelini; Pierino Boschian-Bailo; Monica Buttignol; Andrea Ciavattini
Journal:  Case Rep Obstet Gynecol       Date:  2014-03-16

5.  Conservative treatment in early cervical cancer.

Authors:  Mojgan Karimi-Zarchi; Azamsadat Mousavi; Mitra Modares Gilani; Esmat Barooti; Ashrafosadat Miratashi-Yazdi; Atefe Dehghani
Journal:  Int J Biomed Sci       Date:  2013-09

6.  Analysis of treatment modalities and prognosis on microinvasive cervical cancer: a 10-year cohort study in China.

Authors:  Qiuhong Qian; Jiaxin Yang; Dongyan Cao; Yan You; Jie Chen; Keng Shen
Journal:  J Gynecol Oncol       Date:  2014-06-18       Impact factor: 4.401

7.  Cancer of the cervix uteri: 2021 update.

Authors:  Neerja Bhatla; Daisuke Aoki; Daya Nand Sharma; Rengaswamy Sankaranarayanan
Journal:  Int J Gynaecol Obstet       Date:  2021-10       Impact factor: 4.447

8.  Influence of training level on cervical cone size and resection margin status at conization: a retrospective study.

Authors:  Eliana Montanari; Christoph Grimm; Richard Schwameis; Lorenz Kuessel; Stephan Polterauer; Chiara Paternostro; Heinrich Husslein
Journal:  Arch Gynecol Obstet       Date:  2018-03-30       Impact factor: 2.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.